The North America Amniotic Products Market should witness market growth of 6.8% CAGR during the forecast period (2023-2030).
The amnion membrane is mainly employed for wound healing due to its bacteriostatic and analgesic qualities. The demand for these tissue-based products has recently increased due to greater awareness, which has also raised the number of transplants. This awareness has also increased donations, which has fueled the market's expansion.
Amniotic membranes are frequently utilized for purposes such as limbal stem cell deficiency, regenerative medicine, corneal ulcer treatment, pterygium excision, surgical wounds, leg ulcers caused by pressure and venous leg ulcers, and rebuilding of the conjunctiva surface. Its anti-inflammatory and anti-scarring characteristics are essential in burn injury cases, lowering heightened inflammation and patient suffering.
Therefore, greater awareness of these advantages is projected to spur market expansion. Additionally, they are frequently employed in managing conditions affecting the eye's surface, including bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, corneal degeneration, ocular dystrophy, eyelid reconstruction, and several others.
In the United States alone, 930,000 cases seek outpatient care, and 58,000 attend the emergency department. Corneal ulcers and keratitis are estimated to cause $175 million in direct medical costs per year in the United States. The Canadian Association for Accreditation of Ambulatory Surgical Facilities (CSF) is a national organization created to set and uphold standards to guarantee the safety of surgical procedures outside public hospitals. In Canada, these treatments typically take place in sizable, full-service hospitals despite ASCs being increasingly used to deliver ambulatory interventions in the United States. In light of these elements, the market is predicted to witness growth in the regional market.
The US market dominated the North America Amniotic Products Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $475.7 Million by 2030. The Canada market is poised to grow at a CAGR of 9.2% during (2023-2030). Additionally, The Mexico market should witness a CAGR of 8.2% during (2023-2030).
Based on Type, the market is segmented into Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes. Based on Application, the market is segmented into Wound Care, Ophthalmology, Orthopedics, and Others. Based on End-user, the market is segmented into Hospital & Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
The amnion membrane is mainly employed for wound healing due to its bacteriostatic and analgesic qualities. The demand for these tissue-based products has recently increased due to greater awareness, which has also raised the number of transplants. This awareness has also increased donations, which has fueled the market's expansion.
Amniotic membranes are frequently utilized for purposes such as limbal stem cell deficiency, regenerative medicine, corneal ulcer treatment, pterygium excision, surgical wounds, leg ulcers caused by pressure and venous leg ulcers, and rebuilding of the conjunctiva surface. Its anti-inflammatory and anti-scarring characteristics are essential in burn injury cases, lowering heightened inflammation and patient suffering.
Therefore, greater awareness of these advantages is projected to spur market expansion. Additionally, they are frequently employed in managing conditions affecting the eye's surface, including bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, corneal degeneration, ocular dystrophy, eyelid reconstruction, and several others.
In the United States alone, 930,000 cases seek outpatient care, and 58,000 attend the emergency department. Corneal ulcers and keratitis are estimated to cause $175 million in direct medical costs per year in the United States. The Canadian Association for Accreditation of Ambulatory Surgical Facilities (CSF) is a national organization created to set and uphold standards to guarantee the safety of surgical procedures outside public hospitals. In Canada, these treatments typically take place in sizable, full-service hospitals despite ASCs being increasingly used to deliver ambulatory interventions in the United States. In light of these elements, the market is predicted to witness growth in the regional market.
The US market dominated the North America Amniotic Products Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $475.7 Million by 2030. The Canada market is poised to grow at a CAGR of 9.2% during (2023-2030). Additionally, The Mexico market should witness a CAGR of 8.2% during (2023-2030).
Based on Type, the market is segmented into Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes. Based on Application, the market is segmented into Wound Care, Ophthalmology, Orthopedics, and Others. Based on End-user, the market is segmented into Hospital & Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
Scope of the Study
By Type
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
By Application
- Wound Care
- Ophthalmology
- Orthopedics
- Others
By End-user
- Hospital & Ambulatory Surgical Centers
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- MiMedx Group, Inc.
- Integra LifeSciences Holdings Corporation
- Organogenesis Holdings, Inc.
- Amnio technology LLC
- Alliqua Biomedical, Inc.
- Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
- Corza Ophthalmology (Corza Medical, Inc.)
- BioTissue Holdings, Inc.
- Applied Biologics LLC
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Amniotic Products Market by Type
Chapter 5. North America Amniotic Products Market by Application
Chapter 6. North America Amniotic Products Market by End User
Chapter 7. North America Amniotic Products Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- MiMedx Group, Inc.
- Integra LifeSciences Holdings Corporation
- Organogenesis Holdings, Inc.
- Amnio technology LLC
- Alliqua Biomedical, Inc.
- Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
- Corza Ophthalmology (Corza Medical, Inc.)
- BioTissue Holdings, Inc.
- Applied Biologics LLC
Methodology
LOADING...
